Suyama, T., Hagihara, M., Kubota, N., Osamura, Y., Shinka, Y., & Miyao, N. (2021). Acquired amegakaryocytic thrombocytopenia after durvalumab administration. Journal of Clinical and Experimental Hematopathology, 61(1), 53-57. https://doi.org/10.3960/jslrt.20047
Chicago Style (17th ed.) CitationSuyama, Takahiro, Masao Hagihara, Naoto Kubota, Yoshiyuki Osamura, Yoko Shinka, and Naoki Miyao. "Acquired Amegakaryocytic Thrombocytopenia After Durvalumab Administration." Journal of Clinical and Experimental Hematopathology 61, no. 1 (2021): 53-57. https://doi.org/10.3960/jslrt.20047.
MLA (9th ed.) CitationSuyama, Takahiro, et al. "Acquired Amegakaryocytic Thrombocytopenia After Durvalumab Administration." Journal of Clinical and Experimental Hematopathology, vol. 61, no. 1, 2021, pp. 53-57, https://doi.org/10.3960/jslrt.20047.